SCHEMBL6789331

SCHEMBL6789331

O=C(O)c1cc(C(F)(F)F)cc(C(=O)O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HSD17B10 Q99714 2/20 0.50
RXRA P19793 2/20 0.47
RXRB P28702 2/20 0.47
CES2 O00748 2/20 0.46
RXRG P48443 1/20 0.46
USP2 O75604 1/20 0.43
CYP2C19 P33261 1/20 0.43
GPR35 Q9HC97 1/20 0.42
MCL1 Q07820 1/20 0.42
AKR1C2 P52895 4/20 0.42
AKR1C3 P42330 3/20 0.42
AKR1C1 Q04828 3/20 0.42
AKR1C4 P17516 2/20 0.42
LIPC P11150 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
NOTUM Q6P988 1/20 0.41
XDH P47989 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31335884 0.90 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL24361116 0.88 AKR1C2 (0.51) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL25574138 0.88 CES2 (0.47) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL1752555 0.80 MAPT (0.57) ALDH1A1HPGDCYP2C19GPR35AKR1C2
SCHEMBL28703836 0.80 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL20160881 0.78 RXRA (0.49) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL28717119 0.77 AKR1C2 (0.53) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL30451908 0.77 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL9465832 0.77 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EHSD17B10RXRA
SCHEMBL130628 0.77 ALDH1A1 (0.59) ALDH1A1HPGDKDM4EHSD17B10CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092754-A1 Derivatives of 4-(trifluoromethyl)-phenol and 4-(trifluoromethylphenyl)-2-(tetrahydropyranyl) ether and method for producing the same BASF AKTIENGESELLSCHAFT (DE) 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092754-A1 Derivatives of 4-(trifluoromethyl)-phenol and 4-(trifluoromethylphenyl)-2-(tetrahydropyranyl) ether and method for producing the same EPX, CYP4X1, EPHX2 ALDH1A1 1331/4885HPGD 1212/4885KDM4E 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.